Tuzovic, Mirela
Herrmann, Joerg
Iliescu, Cezar
Marmagkiolis, Kostas
Ziaeian, Boback
Yang, Eric H.
Article History
First Online: 7 April 2018
Compliance with Ethical Standards
:
: Mirela Tuzovic, Cezar Iliescu, Kostas Marmagkiolis, Boback Ziaeian, and Eric H. Yang each declare no potential conflicts of interest.Joerg Herrmann was a participant in the 2014 Ponatinib in CML Cardio-Oncology Advisory Board meeting organized by ARIAD Pharmaceuticals and the 2015 Advisory Board meeting of the Institute for Cardio-Oncology sponsored by Bristol-Myers Squibb.
: This article does not contain any studies with human or animal subjects performed by any of the authors.